Oral dosing with multi-antigenic construct induces atheroprotective immune tolerance to individual peptides in mice-Reference-Cited by-同舟云学术

Oral dosing with multi-antigenic construct induces atheroprotective immune tolerance to individual peptides in mice

Published:2014-08 Issue:2 Volume:175 Page:340-351
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Mundkur Lakshmi,Ponnusamy Thiruvelselvan,Philip Sheena,Rao Lakshmi Narasimha,Biradar Suryakant,Deshpande Vrushali,Kumar Ramesh,Lu Xinjie,Kakkar Vijay V.

Funder

Thrombosis Research Institute

Tata Social Welfare Trust, India

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference50 articles.

1. Inflammation, atherosclerosis, and coronary artery disease;Hansson;N Engl J Med,2005

2. Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis;Hermansson;J Exp Med,2010

3. Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall;Ketelhuth;Thromb Haemost,2011

4. Promise of immune modulation to inhibit atherogenesis;Binder;J Am Coll Cardiol,2007

5. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease;Nilsson;J Intern Med,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two decades of vaccine development against atherosclerosis;Nano Today;2023-06

2. Crosstalk between dendritic cells and T lymphocytes during atherogenesis: Focus on antigen presentation and break of tolerance;Frontiers in Cardiovascular Medicine;2022-07-28

3. Peptidic vaccines: The new cure for heart diseases?;Pharmacological Research;2021-02

4. Long-Term Efficacy and Safety of Immunomodulatory Therapy for Atherosclerosis;Cardiovascular Drugs and Therapy;2019-07-22

5. Hsp60 in Atherosclerosis: Past, Present and Future;Heat Shock Protein 60 in Human Diseases and Disorders;2019